Sequential Patient Recruitment and Allocation for Adaptive Clinical Trials

10/05/2018
by   Onur Atan, et al.
0

Randomized Controlled Trials (RCTs) are the gold standard for comparing the effectiveness of a new treatment to the current one (the control). Most RCTs allocate the patients to the treatment group and the control group by repeated tosses of a fair coin. We show that this procedure can be highly sub-optimal if -- as is often the case -- patients can be recruited in cohorts (rather than all at once), the effects on each cohort can be observed before recruiting the next cohort, and the effects are heterogeneous across groups of patients. We formulate the patient allocation problem as a finite stage Markov Decision Process in which the objective is to minimize a given weighted combination of type-I and type-II errors. Because finding the exact solution to this Markov Decision Process is computationally intractable, we propose an algorithm -- Knowledge Gradient for Randomized Controlled Trials (RCT-KG) -- that yields an approximate solution. We illustrate our algorithm on a synthetic dataset with Bernoulli outcomes, showing that it is significantly more efficient than repeated fair coin tossing. For a given size of trial our method achieves significant reduction in error, and to achieve a prescribed level of confidence (in identifying whether the treatment is superior to the control), our method requires many fewer patients. Our approach uses what has been learned from the effects on previous cohorts to allocate patients in succeeding cohorts, and allocates more patients to subgroups for which the uncertainty is greater.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
12/02/2022

Identifying Heterogeneous Treatment Effects in Multiple Outcomes using Joint Confidence Intervals

Heterogeneous treatment effects (HTEs) are commonly identified during ra...
research
09/29/2021

A Markov Decision Process for Response-Adaptive Randomization in Clinical Trials

In clinical trials, response-adaptive randomization (RAR) has the appeal...
research
05/30/2020

Statistical Decision Properties of Imprecise Trials Assessing COVID-19 Drugs

As the COVID-19 pandemic progresses, researchers are reporting findings ...
research
01/12/2021

Private Randomized Controlled Trials: A Protocol for Industry Scale Deployment

In this paper, we outline a way to deploy a privacy-preserving protocol ...
research
10/21/2016

Learning Cost-Effective Treatment Regimes using Markov Decision Processes

Decision makers, such as doctors and judges, make crucial decisions such...

Please sign up or login with your details

Forgot password? Click here to reset